Similar articles

• The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.

  Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, Godfrey-Faussett P, Beyers N. Hesseling AC, et al. Vaccine. 2007 Jan 2;25(1):14-8. doi: 10.1016/j.vaccine.2006.07.020. Epub 2006 Aug 1. Vaccine. 2007. PMID: 16959383
• The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.

  [No authors listed] [No authors listed] MMWR Recomm Rep. 1996 Apr 26;45(RR-4):1-18. MMWR Recomm Rep. 1996. PMID: 8602127
• Bacillus Calmette-Guérin infection after vaccination of human immunodeficiency virus-infected children.

  Besnard M, Sauvion S, Offredo C, Gaudelus J, Gaillard JL, Veber F, Blanche S. Besnard M, et al. Pediatr Infect Dis J. 1993 Dec;12(12):993-7. doi: 10.1097/00006454-199312000-00006. Pediatr Infect Dis J. 1993. PMID: 8108227
• Childhood tuberculosis and infection with the human immunodeficiency virus. BCG immunization for HIV-seropositive newborns.

  Bonifachich E. Bonifachich E. Pediatr Pulmonol Suppl. 1997;16:157-9. doi: 10.1002/ppul.1950230884. Pediatr Pulmonol Suppl. 1997. PMID: 9443252 Review. No abstract available.
• Possible hazards of routine bacillus Calmette-Guérin immunization in human immunodeficiency virus-infected children.

  Edwards KM, Kernodle DS. Edwards KM, et al. Pediatr Infect Dis J. 1996 Sep;15(9):836-8. doi: 10.1097/00006454-199609000-00023. Pediatr Infect Dis J. 1996. PMID: 8878234 Review. No abstract available.